Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-κB target genes in human breast cancer-Reference-Cited by-同舟云学术

Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-κB target genes in human breast cancer

Published:2013-11-23 Issue:1 Volume:5 Page:196-210
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Dalmases Alba¹²,González Irene¹²,Menendez Silvia¹²,Arpí Oriol¹²,Corominas Josep Maria³,Servitja Sonia¹²,Tusquets Ignasi¹²⁴,Chamizo Cristina⁵,Rincón Raúl⁵,Espinosa Lluis¹,Bigas Anna¹,Eroles Pilar⁵,Furriol Jessica⁵,Lluch Anna⁶⁷,Rovira Ana¹²,Albanell Joan¹²⁸,Rojo Federico¹⁵

Affiliation:

1. Cancer Research Program, IMIM (Hospital del Mar Research Institute), Barcelona, Spain;

2. Medical Oncology Department, Hospital del Mar, Barcelona, Spain;

3. Pathology Department, Hospital del Mar, Barcelona, Spain;

4. Autonomous University of Barcelona, Spain;

5. Pathology Department, IIS-Fundación Jiménez Díaz, Madrid, Spain;

6. Oncology and Hematology Department, Hospital Clinico Universitario, Valencia, Spain;

7. Valencia Central University, Spain;

8. Universitat Pompeu Fabra, Barcelona, Spain

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Abl1 tyrosine kinase is a key player in doxorubicin-induced cardiomyopathy and its p53/p73 cell death mediated signaling differs in atrial and ventricular cardiomyocytes;2024-07-10

2. A Review on Picrosides Targeting NFκB and its Proteins for Treatment of Breast Cancer;Cell Biochemistry and Biophysics;2024-05-09

3. The Abl1 Tyrosine Kinase and p53 are Key Players in Doxorubicin-Induced Cardiomyopathy and Their Cell Death Signaling Differs in Atrial and Ventricular Cardiomyocytes;2024

4. Enhancing therapeutic efficacy in breast cancer: a study on the combined cytotoxic effects of doxorubicin and MPC-3100;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-11-02

5. Cell plasticity modulation by flavonoids in resistant breast carcinoma targeting the nuclear factor kappa B signaling;Cancer and Metastasis Reviews;2023-10-04